Rockwell Medical, Inc.
RMTI
$1.03
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 24.67M | 28.32M | 25.83M | 22.68M | 22.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.67M | 28.32M | 25.83M | 22.68M | 22.09M |
| Cost of Revenue | 21.03M | 22.08M | 21.28M | 19.61M | 19.22M |
| Gross Profit | 3.63M | 6.24M | 4.55M | 3.06M | 2.87M |
| SG&A Expenses | 4.15M | 4.30M | 4.04M | 4.37M | 3.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.18M | 26.38M | 25.32M | 24.00M | 22.64M |
| Operating Income | -519.00K | 1.94M | 515.00K | -1.32M | -547.00K |
| Income Before Tax | -756.00K | 1.66M | 343.00K | -1.73M | -1.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -756.00K | 1.66M | 343.00K | -1.73M | -1.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -756.00K | 1.66M | 343.00K | -1.73M | -1.51M |
| EBIT | -519.00K | 1.94M | 515.00K | -1.32M | -547.00K |
| EBITDA | 24.00K | 2.48M | 1.06M | -779.00K | 3.00K |
| EPS Basic | -0.03 | 0.05 | 0.01 | -0.06 | -0.06 |
| Normalized Basic EPS | -0.01 | 0.03 | 0.01 | -0.04 | -0.04 |
| EPS Diluted | -0.03 | 0.04 | 0.01 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.01 | 0.03 | 0.01 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 32.88M | 31.55M | 30.45M | 29.33M | 28.65M |
| Average Diluted Shares Outstanding | 32.88M | 32.42M | 32.03M | 29.33M | 28.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |